Skip to main content
. 2019 Apr 29;21(4):61. doi: 10.1208/s12248-019-0323-0

Fig. 5.

Fig. 5

Changes in outcome parameters between the first and second scans for the [11C]erlotinib + rifampicin data set. k1, k2, k3, and k5 values obtained in individual subjects for each model in scan 1 and scan 2. ns, not significant; *p ≤ 0.05, two-tailed paired t test